Despite widespread use of vaccines to prevent human papillomavirus (HPV) and screening for early detection and treatment, a study by the BMJ found that the incidence of advanced cervical cancer has increased in the United States over the past two decades. International Journal of Gynecological Cancer It was published on the 18th.
UCLA’s Alex Andrea Francoeur and his team analyzed data from 2001 to 2018 using the American Cancer Statistics program.
In the past 18 years, 29,715 women were diagnosed with late-stage cervical cancer.
As a result of the study, black women (1.55 per 100,000) were significantly higher than white women (0.92).
Looking at the trend over time, late-stage cervical cancer is increasing every year at a rate of 1.3% per year.
The largest increase was seen in cervical adenocarcinoma, which increased at an average annual rate of 2.9%.
End-stage cervical cancer was higher in black and Hispanic women than in white women.
In contrast, white women had the steepest annual increase in the incidence of advanced cancer and had the lowest rates of HPV vaccination among white adolescents.
In the South, white women aged 40-44 years had the highest annual incidence of advanced cervical cancer (4.5%) and were significantly less likely to receive timely screening for cervical cancer.
The research team wrote, “We need to take action to increase the importance of regular inspection and testing.”
Send articles on social media
